Performance Period: 2/1/2019 to 12/31/2020
Single-use technology has been widely adopted in the biopharmaceutical industry. Results from a 2015 survey reported in BioPharm International show that 87% of respondents to a “manufacturing trends and outlook” survey reported using single-use components in their processes. Despite the wide adoption of single-use technology, the availability of hands-on training opportunities, particularly those that incorporate an actual bioprocess, are limited.
This is the first phase of a larger project that will assemble the single-use equipment and develop a process for monoclonal antibody (mAb) production in CHO to be used for education/training and development projects. The project would lead to the first dedicated single-use mAb production process for education, training, testing and development of which we are aware.
 R. Peters, "Technologies and Practices Must Evolve to Meet Demand,” BioPharm International, Vol 28 (1) 2015
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
North Carolina State University